Funding for this research was provided by:
Università degli Studi di Milano
Article History
Accepted: 3 June 2024
First Online: 1 July 2024
Declarations
:
: E.G.F. has received consulting fees and/or honoraria from Alfasigma, AbbVie, BMS, Galapagos, Janssen, Lilly, MSD, Novartis, Pfizer and UCB. G.M. has received consulting fees and/or honoraria from Janssen and Lilly. R.C. has received consulting fees and/or honoraria from AbbVie, Amgen, BMS, Celltrion, Fresenius, Galapagos, Janssen, Lilly, Novartis, Pfizer and UCB.
: Open access funding provided by Università degli Studi di Milano within the CRUI-CARE Agreement.
: Not applicable.
: Not applicable.
: Not applicable.
: No data were used for the research described in the article.
: Not applicable.
: E.G.F. and G.M. conceived, designed and wrote the manuscript; collected data; and performed literature analysis and interpretation. R.C. supervised the drafting and contributed to the final version of the manuscript.